| Jun 7 |
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?
|
| Jun 6 |
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
| Jun 3 |
Gilead, Arcus combo significantly reduces death risk in colorectal cancer
|
| Jun 3 |
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
|
| Jun 2 |
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
|
| Jun 1 |
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
|
| May 31 |
It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year
|
| May 26 |
Wall Street Breakfast: The Week Ahead
|
